Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial

Clinical trial NCT05280132 · RECRUITING

Trial details

NCT number: NCT05280132
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Exacerbation of COPD

Start date: 2022-12-08
Primary completion: 2026-04-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.